Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 May 20;16(5):e0251725. doi: 10.1371/journal.pone.0251725

Self-medication practice and contributing factors among pregnant women

Yirga Legesse Niriayo 1,*, Kadra Mohammed 1, Solomon Weldegebreal Asgedom 1, Gebre Teklemariam Demoz 2, Shishay Wahdey 3, Kidu Gidey 1
Editor: Denis Bourgeois4
PMCID: PMC8136661  PMID: 34014975

Abstract

Background

The practice of self-medication during pregnancy is a global challenge that necessitates high attention as it poses a potential threat to the pregnant mother and fetus. However, little is known regarding self-medication practice and its contributors among pregnant women in our setting.

Objective

The main aim of this study was to investigate the practice of self-medication and its contributing factors among pregnant women

Methodology

A cross sectional study was conducted among pregnant women at antenatal care follow-up of Ayder comprehensive specialized hospital, Tigray, Ethiopia. Written informed consent was obtained from each participant before interview. Simple random sampling technique was employed to recruit participants in to the study. Data were collected by interviewing participants using the structured questionnaire. Binary logistic regressions analysis was performed to determine the contributing factors of self-medication practice during pregnancy. A p value of less than 0.05 was considered as significant.

Results

A total of 250 pregnant women were included in the study. Of the total, 40.8% practiced self-medication during the current pregnancy. Morning sickness (39.2%), headache (34.3%), and upper respiratory tract infections (29.4%) were the leading indications for self-medication. According to participant report, ease of access to medicines (25.5%), feelings that the disease is minor (21.6%) and timesaving (19.6%) were the most commonly reported reasons for self-medication practice. Absence of health insurance (AOR: 2.75, 95%CI: 1.29–5.89) and being on first trimester of pregnancy (AOR: 2.44, 95%CI: 1.02–5.86) were significant contributors of self-medication practice among pregnant women.

Conclusion

In our study, high prevalence of self-medication was reported among pregnant women. Self-medication practice during pregnancy was higher among pregnant women on first trimester and those who were not having health insurance. Therefore, intervention programs should be designed to minimize the practice of self-medication during pregnancy.

Introduction

According to the World Health Organization (WHO), self-medication is defined as the act of using medications by patients or individuals to treat self-diagnosed disorders or symptoms on their own initiative without getting advice from health care provider [13]. Self- medication includes use of over counter drugs available without a physician’s prescription, irregular use of prescribed medicines, use of leftover drugs from previous prescriptions, and use of herbal and traditional medicines [4,5]. Owing to the limited access to health care service and scarcity of resources, the practice of self-medication is common in developing countries including Ethiopia [6,7]. According to the meta-analysis reported in 2018, the prevalence of self-medication in Ethiopia ranged from 12.5%-78.1% with an average of 44% [8].

The practice of self-medication during pregnancy has been increasing worldwide, particularly in developing countries owing to the poor health care system [911]. Likewise, the practice of self-medication during pregnancy is increasing in Ethiopia with a reported prevalence ranged from 15.5%-70% [8,12,13].

In clinical practice, self-medication during pregnancy still remained a significant medical challenge [14,15]. Although drugs are frequently used during pregnancy in clinical practice, their safety has not been well-established as pregnant women are often excluded from clinical trials due to the fear of harm on the mother or the developing fetus [15,16]. Therefore, unless absolutely necessary, drugs should be avoided during pregnancy [17]. Despite this fact, there is high level of self-medication use during pregnancy [18]. Self-medication can affect both the fetus and the mother and it could cause detrimental effects on the fetus including malformation/teratogenicity, fetal toxicity, low birth weight, premature birth, respiratory problems as well as death [15,18,19]. It has been reported that at least 10% of birth defects are resulted from the exposure of pregnant women to drugs [15].

The prevalence of self-medication varies across different communities and it could be affected by several factors including lack of access to healthcare service, unregulated distribution of medicines, patients’ attitudes toward healthcare providers, socio-economic factors, long waiting times, cost of the drugs, educational level, age, income, education level, satisfaction, and belief of people’s toward medication and disease [9,12,2022].

Despite the potential harmful effect of self-mediation practice during pregnancy [15,16], there is little awareness about the impact of self-medication practice among pregnant mothers in developing countries including Ethiopia [7,10,23,24]. Hence, evaluation of self-medication practice and its contributors will provide information for health policy makers and relevant stakeholders to develop strategies to prevent the risks associated with self-medication practice during pregnancy. In our setting, though there are some studies on self-medication in general population [7,8], studies regarding self-medication practices during pregnancy are scanty. Our study, therefore, investigated the practice of self-medication and its contributing factors during pregnancy.

Methodology

Study design and setting

An institutional based cross-sectional study was conducted from January to April 2019 at antenatal care follow up of Ayder comprehensive specialized hospital (ACSH), Tigray region, Ethiopia. ACSH is the largest public hospital in Tigray region whiles it the second in Ethiopia next to black lion hospital. It provides service for about 10 million people in the catchment area.

Study participants and data collection procedure

All pregnant mothers who had antenatal care (ANC) follow up in ACSH were the source population. Pregnant women at any gestational age who came for ANC to ACSH hospital during the study period were included in this study. Pregnant women who are critically ill to give response, unable to hear/communicate and those who are unwilling to give consent were excluded from the study.

The sample size for this study was determined using the single population proportion formula for the prevalence of self-medication practice. Accordingly a sample of 262 participants was calculated assuming 26.6% prevalence of self-medication practice during pregnancy according to a study conducted in Addis Abeba [24], 95% confidence level, 5% margin of error, and 10% contingency for nonresponse rate. From 262 participants approached, 12 patients were excluded from the study due to unable to hear [1], critically ill to give response [4], and unwillingness to give consent [7]. The participants were recruited into the study during their appointment for ANC using simple random sampling technique.

We collected the data using an interviewer administered structured questionnaire (S1 Table). The questionnaire was developed based on previous studies [9,13,14] and it was amended to fit the current study. The questionnaire was translated to local language (Tigrigna), and then back translated to English to ensure consistency of meaning. Pre-test was carried out on 5% of the sample before the commencement of the actual data collection and slight amendments were made on the questionnaire based on the findings. The questionnaire involves data related to socio-demographics, obstetrics factor, and self-medication practices. Fifth year clerkship pharmacy students were employed to collect the data for this study and they were given training and orientation.

Statistical analysis

We analyzed the data using the Statistical Package for the Social Science (SPSS version 24.0) (S2 Table). Descriptive statics was computed as frequency, mean and standard deviation (SD). Multicollinearity was checked to test correlation among predictor variables using variance inflation factor (VIF) and none was collinear. The association of each independent variable with self-medication practice was determined using univariable logistic regression analysis. Furthermore, the variables with p value <0.25 in univariable analysis were re-analyzed using multivariable binary logistic regression model to identify the independent predictors of self-medication practice during pregnancy. A p value of <0.05 was considered statistically significant in all analyses.

Ethics

This study was approved by ethics review committee of school of pharmacy, College of Health Sciences, Mekelle University. Each study participant was well informed about the objective of the study. After getting permission from the ACSH hospital, written informed consent was obtained from all participants. Confidentiality was assured for all the information provided. All the methods were performed in accordance with approved institutional guidelines.

Result

Socio-demographic characteristics

A total of 250 participants were included in this study. The mean (±SD) age was 26.9±5.42. Most (83.6%) of the participants have attended primary school and above. Nearly half (46.4%) were housewives. Majority of the participants were from urban. The mean income was 4543.42±3436.23 Ethiopian Birr. Alcohol consumption was reported in 17.2% of the participants (Table 1).

Table 1. Socio-demographic characteristics of participants (n = 250).

Category Frequency (%)
Age
≤18 2(0.8)
19–25 115(46)
26–30 83(33)
31–35 34(13.6)
>35 16(6.4)
Residence
Urban 183(73.2)
Rural 67(26.8)
Educational status
No formal education 36(14)
Primary 41(16.4)
Secondary 108(43.2)
Higher education 65(26)
Occupation
Civil servant 59(23.6)
Merchant 50(20)
Housewife 116(46.4)
Others 25(10)
Income
<5000 126(50.4)
> = 5000 124(49.6)
Chronic illness
Yes 11(4.4)
No 239(95.6)
Alcohol
No 207(82.8)
Yes 43(17.2)
Health insurance
Yes 53(21.2)
No 197(78.8)

Obstetric factors

Nearly half (44.8%) of the participants were in the first trimester of their pregnancy and majority (66%) were multigravidas. About two-thirds (62.8%) of participants had ANC follow-up in their previous pregnancy and 16.8% experienced complications related to previous pregnancy (Table 2).

Table 2. Obstetrics characteristics of study participants, 2019(n = 250).

Category Frequency (%)
Gestational period
First trimester 112(44.8)
Second trimester 101(40.4)
Third trimester 37(14.8)
Gravidity
Primeravida 85(34)
Mutigravida 165(66%)
Previous ANC follow up
Yes 157(62.8)
No 93(37.2)
Place of delivery of last baby
Home 8(4.8)
Health institution 157(93.2)
Previous still birth
No 227(90.8)
Yes 23(9.2)
Previous pregnancy related complications
Yes 42(16.8)
No 208(83.2)

Self-medication practice during pregnancy

Of the total, 40.8% practiced self-medication during the current pregnancy while one-fourth (25.2%) of participants had previous self-medication experience. Among those who used self-medication (102), 43(42.2%) medicated themselves with modern medicine and 41(40.2%) used traditional medicine while 18(17.6%) used both modern medicine and traditional medicine. The participants mentioned deferent reasons for self-medication. Among those, the major reasons for self-medication were easily accessing medicines (25.5%), feeling that the disease is minor (21.6%), and timesaving (19.6%). Morning sickness (39.2%), headache (34.3), and upper respiratory tract infections (29.4%) were the most common indications for self- medication (Table 3).

Table 3. Self-medication practice during pregnancy, 2019(n = 250).

Characteristics Frequency (%)
Self-medication
Yes 102(40.8)
No 148(59.2)
History of previous self-medication
Yes 63(25.2)
No 187(74.8)
Type of medicine used
Modern only 43(42.2)
TDM only 36(18.5)
Both modern and TDM 18(17.6)
Reason for self-medication
Easily accessing medicines 26(25.5)
Disease not serious 22(21.6)
Timesaving 20(19.6)
Poor health service provision 15(14.7)
Cost saving 13(12.7)
Lack of trust on prescribers 6(5.9)
Common Indications for self-medication
Morning sickness 40(39.2)
Headache 35(34.3)
Upper respiratory tract infections 30(29.4)
Dyspepsia 22(21.6)
Urinary tract infections 20(19.6)
Cough and cold 16(15.7)
Diarrhea 14(13.7)
Allergic rhinitis 8(7.8)
Source of modern medication for self-medication
Pharmacies/drug stores 60(24)
Leftover medicine 32(12.8)
Sharing with family, friends or neighbors 10(4)

Factors associated with self-medication practice during pregnancy

Independent variables including age, residence, educational status, occupation, income, presence of chronic illness, alcohol, health insurance, gestational period, gravidity, still birth, delivery place of last baby, prior pregnancy related complications, and prior ANC follow-up were analyzed using univariable logistic regression analysis to assess their association with self-medication practice.

Accordingly, gestational age (COR:2.90,95%CI:1.25–6.70), health insurance (COR:3.06,95% CI:1.63–5.74), gravidity (COR:1.79, 95%CI:1.03–3.10) were significantly associated with self-medication practice in univariate analysis. Moreover, variables with P<0.25 in the univariable analyses including residence, educational status, chronic illness, health insurance, gestational age, gravidity, and previous pregnancy related complications were re-analyzed using multivariable logistic regression model. The whole model containing all predictors was statistically significant (Chi-square = 27.676, df = 10, P = 0.002). In multivariable logistic regression analysis, participants without health insurance (AOR: 2.75, 95%CI: 1.29–5.89) and participants on first trimester (AOR: 2.44, 95%CI: 1.02–5.86) were more likely to practice self-medication compared to those with health insurance and on third trimester, respectively (Table 4).

Table 4. Factors associated with self-medication practice during pregnancy (n = 250).

Characteristics Self-medication COR (95% CI) p-value AOR (95% CI) p-value
No, n (%) Yes, n(%)
Residence
Urban 113(76.4) 70(68.6) 1 1
Rural 35(23.6) 32(31.4) 1.48(0.84–2.60) 0.177 0.80(0.37–1.74) 0.577
Educational status
No formal education 18(12.2) 18(17.) 1.41(0.62–3.19) 0.82(0.29–2.29) 0.702
Primary 17(11.5) 24(23.5) 1.99(0.90–4.30) 068 1.30(0.52–3.21) 0.574
Secondary 75(50.7) 33(32.4) 0.62(0.33–1.17) 0.60(0.30–1.15) 0.123
College and above 38(25.7) 27(26.5) 1 1
Chronic illness
No 144(97.3) 95(93.1) 1 1
Yes 4(2.7) 7(6.9) 2.653(0.756–9.310)  0.128  1.228(0.237–6.36) 0.807
Health insurance
Yes 20(13.5) 33(32.4) 1 1
No 128(86.5) 69(67.6)  3.061(1.634–5.735) <0.001 2.75(1.29–5.89) 0.009
Gravidity 58(39.2) 27(26.5)  1 1
Primigravida 90(60.8) 75(73.5) 1.228(0.64- 2.354) 0.537  0.63(0.34–1.18) 0.152
Multigravida 58(39.2) 27(26.5)  1 1
Previous pregnancy related complication
No 128(86.5) 80(78.4) 1 1
Yes 20(13.5)  22(21.6)  2.669(1.202–5.926) 0.016  1.20(0.56–2.61) 0.637
Gestational age
First trimester 58(39.2) 54(52.9) 2.99(1.25–6.69) 0.036 2.44(1.02–5.9) 0.045
Second trimester 62(41.9) 39(38.2) 1.96(0.84–4.58) 1.87(0.77–4.54) 0.166
Third trimester 28(18.9) 9(8.8) 1 1

Discussion

The practice of self-medication is a global challenge that necessitates high attention because it poses a potential threat to the pregnant mother and fetus [14,25]. In developing countries including Ethiopia, clinicians may not be aware of the actual burden of self-medication and its contributing factors during pregnancy. Thus, conducting such kind of study will help them to design and develop strategies to prevent/minimize self-medication practice during pregnancy. Our study, therefore, investigated the practice of self-medication and its contributing factors among pregnant women. The current study revealed that a significant proportion of pregnant women practiced self-medication either with modern and/or herbal medicine without consulting healthcare professionals.

Despite the potential harmful effect of self-mediation during pregnancy [15,16], nearly half (40.8%) of pregnant women practiced self-medication during their current pregnancy. This result is comparable with the findings reported from Tanzania [14] and Iran [22]. In contrast, higher findings were reported from previous studies conducted in Democratic Republic of Congo [26], Nigeria [27] and Ethiopia [12]. On the other hand, our finding is higher compared to the findings reported from Addis Abeba [24] and Netherland [28]. These variations could be attributed to the differences in level of awareness about risks of self-medication in pregnancy, population demographics, access to healthcare service, and restriction policies of dispensing practices.

Morning sickness, headache, and upper respiratory tract infections were the leading indications for self-medication in this study. In Tanzanian study [14], malaria, morning sickness, and headache were the leading illness that led to self-medication. Unlike our study, malaria was the most common indication for self-medication in Tanzanian study [14]. This could be due to the less prevalence of malaria in our study setting.

In the present study, the most commonly reported reasons for self-medication practice during pregnancy were ease of access to medicines, feeling that disease is minor and prolonged waiting time. In agreement with our study, similar finding were reported from previous studies conducted in Addis Ababa [24] and democratic republic of Congo [26]. The ease of access to medications without prescription could be attributed to the poor drug regulatory system and weak enforcement on restricting prescription drugs sale without prescription as well as nonprescription drugs sale to pregnant women. Moreover, it could be augmented due to the lack of attention and priorities of health policy makers and other stakeholders on the burden of self-medication risks [24]. Therefore, necessary measures should be taken to strengthen regulatory system and enforce regulations so as to reduce the practice of self-medication during pregnancy.

Our study revealed that pregnant women without health insurance were more prone to self-medication practice which is consistent with a finding reported from Iran [22]. The possible explanation is that those who have health insurance are more likely to visit health institution and see a doctor. Thus, they are more likely to get prescribed medication as the cost of their visit and medication can be compensated by the insurance.

Pregnant women on first trimester were more likely to practice self-medication compared to those on third trimester. This finding is supported by a study conducted in Tanzania [14]. The possible justification for higher self-medication practice during first trimester of pregnancy could be due to the more frequent occurrence of symptoms and/or illnesses including morning sickness, headache, and fever in the first trimester than other trimester during pregnancy. More importantly, this finding is worrisome as drug exposure in this period is more likely to cause congenital abnormalities [2931]. Therefore, more emphasis should be given to the use of medication during first trimester of pregnancy.

Finally, our study had some limitations. Our study was a cross–sectional suggesting that it cannot provide adequate evidence of causality regarding self-medication and its contributing factors. During interview, pregnant women were expected to recall information from their past experience; therefore, recall bias might affect the study findings. The findings of our study could be affected by the difference in population demographics, healthcare system and regulations and knowledge of the participants. Therefore, it should be extrapolated to other countries with caution.

Conclusion

In our study, a high prevalence of self-medication was reported among pregnant women. Self-medication practice during pregnancy was higher among pregnant women on first trimester and those who were not having health insurance. Therefore, healthcare providers should provide more emphasis to the risky participants and implementation of national health insurance needs to be encouraged. Moreover, intervention programs should be designed to minimize the practice of self-medication during pregnancy.

Supporting information

S1 Table. Data collection instrument.

(DOC)

S2 Table. Dataset.

(SAV)

Acknowledgments

We would like to acknowledge the data collectors and the hospital staff for their genuine cooperation. Our gratefulness goes to the pregnant women for their eager involvement in the study.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Rutter P. Role of community pharmacists in patients’ self-care and self-medication. Integrated pharmacy research & practice. 2015;4:57. 10.2147/IPRP.S70403 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Mahapatra T. Self-care and self-medication: A commentary. Annals of Tropical Medicine and Public Health. 2017;10(3):505. [Google Scholar]
  • 3.World Health Organization. Guidelines for the regulatory assessment of Medicinal Products for use in self-medication. World Health Organization, 2000. [Google Scholar]
  • 4.Pfaffenbach G, Tourinho FS, Bucaretchi F. Self-medication among children and adolescents. Current drug safety. 2010;5(4):324–8. 10.2174/157488610792246028 [DOI] [PubMed] [Google Scholar]
  • 5.Bennadi D. Self-medication: A current challenge. Journal of basic and clinical pharmacy. 2013;5(1):19. 10.4103/0976-0105.128253 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Parulekar M, Mekoth N, Ramesh C, Parulekar A. Self medication in developing countries a systematic review. Journal of Pharmaceutical Technology. 2016;4(2):103–27. [Google Scholar]
  • 7.Ayalew MB. Self-medication practice in Ethiopia: a systematic review. Patient preference and adherence. 2017;11:401–13. 10.2147/PPA.S131496 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Sisay M, Mengistu G, Edessa D. Epidemiology of self-medication in Ethiopia: a systematic review and meta-analysis of observational studies. BMC Pharmacol Toxicol. 2018;19(1):56. 10.1186/s40360-018-0248-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Abeje G, Admasie C, Wasie B. Factors associated with self medication practice among pregnant mothers attending antenatal care at governmental health centers in Bahir Dar city administration, Northwest Ethiopia, a cross sectional study. The Pan African medical journal. 2015;20:276. 10.11604/pamj.2015.20.276.4243 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Kureshee NI, Dhande PP. Awareness of Mothers and Doctors about Drug Utilization Pattern for Illnesses Encountered during Pregnancy. J Clin Diagn Res. 2013;7(11):2470–4. 10.7860/JCDR/2013/6329.3582 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Adanikin AI, Awoleke JO. Antenatal drug consumption: the burden of self-medication in a developing world setting. Tropical doctor. 2017;47(3):193–7. 10.1177/0049475516653067 [DOI] [PubMed] [Google Scholar]
  • 12.Jambo A, Mengistu G, Sisay M, Amare F, Edessa D. Self-Medication and Contributing Factors Among Pregnant Women Attending Antenatal Care at Public Hospitals of Harar Town, Ethiopia. Front Pharmacol. 2018;9:1063. 10.3389/fphar.2018.01063 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Zewdie T, Azale T, Shimeka A, Lakew AM. Self-medication during pregnancy and associated factors among pregnant women in Goba town, southeast Ethiopia: a community based cross sectional study. BMC research notes. 2018;11(1):713. 10.1186/s13104-018-3821-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Marwa KJ, Njalika A, Ruganuza D, Katabalo D, Kamugisha E. Self-medication among pregnant women attending antenatal clinic at Makongoro health centre in Mwanza, Tanzania: a challenge to health systems. BMC Pregnancy Childbirth. 2018;18(1):16. 10.1186/s12884-017-1642-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Nakamura MU, Kulay Junior L, Pasquale M. [Use of drugs during pregnancy: benefit and cost]. Revista brasileira de ginecologia e obstetricia: revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia. 2008;30(1):1–4. 10.1590/s0100-72032008000100001 [DOI] [PubMed] [Google Scholar]
  • 16.Araújo DD, Leal MM, Santos EJV, Leal LB. Consumption of medicines in high-risk pregnancy: evaluation of determinants related to the use of prescription drugs and self-medication. Brazilian Journal of Pharmaceutical Sciences. 2013;49(3):491–9. [Google Scholar]
  • 17.Sachdeva P, Patel BG, Patel BK. Drug use in pregnancy; a point to ponder!. Indian J Pharm Sci. 2009;71(1):1–7. 10.4103/0250-474X.51941 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Rahmani A, Hamanajm SA, Fallahi A, Ghanei Gheshlagh R, Dalvand S. Prevalence of self-medication among pregnant Women: A systematic review and meta-analysis. Nursing and Midwifery Studies. 2019;8(4):169–75. [Google Scholar]
  • 19.Ciarkowski SL, Stalburg CM. Medication safety in obstetrics and gynecology. Clinical obstetrics and gynecology. 2010;53(3):482–99. 10.1097/GRF.0b013e3181ec14c0 [DOI] [PubMed] [Google Scholar]
  • 20.Karimy M, Rezaee-Momtaz M, Tavousi M, Montazeri A, Araban M. Risk factors associated with self-medication among women in Iran. BMC public health. 2019;19(1):1033. 10.1186/s12889-019-7302-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Bello FA, Morhason-Bello IO, Olayemi O, Adekunle AO. Patterns and predictors of self-medication amongst antenatal clients in Ibadan, Nigeria. Niger Med J. 2011;52(3):153–7. 10.4103/0300-1652.86124 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Ebrahimi H, Atashsokhan G, Amanpour F, Hamidzadeh A. Self-medication and its risk factors among women before and during pregnancy. The Pan African medical journal. 2017;27:183. 10.11604/pamj.2017.27.183.10030 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Nergard CS, Ho TPT, Diallo D, Ballo N, Paulsen BS, Nordeng H. Attitudes and use of medicinal plants during pregnancy among women at health care centers in three regions of Mali, West-Africa. J Ethnobiol Ethnomed. 2015;11:73. 10.1186/s13002-015-0057-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Beyene KGM, Beza SW. Self-medication practice and associated factors among pregnant women in Addis Ababa, Ethiopia. Tropical medicine and health. 2018;46:10. 10.1186/s41182-018-0091-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Adanikin AI, Awoleke JO. Antenatal drug consumption: the burden of self-medication in a developing world setting. Trop Doct. 2017;47(3):193–7. 10.1177/0049475516653067 [DOI] [PubMed] [Google Scholar]
  • 26.Mbarambara PM, Songa PB, Wansubi LM, Mututa PM, Minga BBK, Bisangamo CK. Self-medication practice among pregnant women attending antenatal care at health centers in Bukavu, Eastern DR Congo. International Journal of Innovation and Applied Studies. 2016;16(1):38. [Google Scholar]
  • 27.Abasiubong F, Bassey EA, Udobang JA, Akinbami OS, Udoh SB, Idung AU. Self-Medication: potential risks and hazards among pregnant women in Uyo, Nigeria. The Pan African medical journal. 2012;13:15. [PMC free article] [PubMed] [Google Scholar]
  • 28.Verstappen GM, Smolders EJ, Munster JM, Aarnoudse JG, Hak E. Prevalence and predictors of over-the-counter medication use among pregnant women: a cross-sectional study in the Netherlands. BMC public health. 2013;13:185. 10.1186/1471-2458-13-185 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Ban L, West J, Gibson JE, Fiaschi L, Sokal R, Doyle P, et al. First trimester exposure to anxiolytic and hypnotic drugs and the risks of major congenital anomalies: a United Kingdom population-based cohort study. PLoS One. 2014;9(6):e100996. 10.1371/journal.pone.0100996 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Mashuda F, Zuechner A, Chalya PL, Kidenya BR, Manyama M. Pattern and factors associated with congenital anomalies among young infants admitted at Bugando medical centre, Mwanza, Tanzania. BMC research notes. 2014;7(1):1–7. 10.1186/1756-0500-7-195 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Dellicour S, Sevene E, McGready R, Tinto H, Mosha D, Manyando C, et al. First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: A meta-analysis of observational studies. PLoS Med. 2017;14(5):e1002290-e. 10.1371/journal.pmed.1002290 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Denis Bourgeois

4 Dec 2020

PONE-D-20-32462

Self-medication practice and contributing factors among pregnant women

PLOS ONE

Dear Dr. Niriayo,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jan 09 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Denis Bourgeois

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2.  For more information on PLOS ONE's expectations for statistical reporting, please see https://journals.plos.org/plosone/s/submission-guidelines.#loc-statistical-reporting. Please update your Methods and Results sections accordingly.

3. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information.  If the original language is written in non-Latin characters, for example Amharic, Chinese, or Korean, please use a file format that ensures these characters are visible.

4.  We noticed you have some minor occurrence of overlapping text with the following previous publication(s), which needs to be addressed:

- https://tropmedhealth.biomedcentral.com/articles/10.1186/s41182-018-0091-z

In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the methods section. Further consideration is dependent on these concerns being addressed.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Overall, the text is well organized and structured according to IMRED. The writing style is pleasant. However, the presentation of tables does not meet current standards for presentation of a table. It will remove the left and right borders and remove the intermediate lines only the bottom line and the variable banner (the 2 top lines).

There are also shortcomings in the presentation of the references, in particular reference 17 to be corrected.

The study population is well specified. Sample size and selection methods are also described.The ethical and regulatory aspects have been taken into account.

The analyses are in agreement with the study scheme. Statistical analyses are carried out to high technical standards and are described in sufficient detail. However, we should have presented the results of the univariate analysis with the overall p value for a variable instead of the p value per variable category; especially for variables with more than 2 modalities. In the presentation of table 4, for the reference modality, the p value must not appear (in yellow in the table). The presentation of Table 4 needs to be improved. Make a clear distinction between the variables that were used for the univariate analysis and those that were retained for the multivariate analysis.

The results meet the targeted objectives. The limits and biases as well as the impact of its biases are well mentioned.

The manuscript as a whole is well organized and clearly written enough to be accessible even to non-specialists. The few shortcomings noted have no major impact on the study, which remains solid but which requires some corrections.

Reviewer #2: This is a very interesting study : it could help to support and develop information and national and international prevention programs for pregnant women about the dangers of automédication for themselves and their fetus.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Jocelyne V. W. GARE

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-20-32462_reviewer_GARE.pdf

PLoS One. 2021 May 20;16(5):e0251725. doi: 10.1371/journal.pone.0251725.r002

Author response to Decision Letter 0


29 Apr 2021

Manuscript number: PONE-D-20-32462

Title: “Self-medication practice and contributing factors among pregnant women”

Authors: Yirga Legesse Niriayo*1, Kadra Mohammed1, Solomon Weldegebreal Asgedom1, Gebre Teklemariam Demoz2, Shishay Wahdey3 Kidu Gidey 1,

Authors’ response to academic editor’s and reviewers’ comments

We thank the academic editor and the reviewer for reviewing our manuscript. We greatly appreciate the academic editor and reviewers for their constructive comments and suggestions on our submitted manuscript. We have modified our manuscript based on the editor and reviewer comments and suggestions. We offer below responses to each of the points raised by the academic editor and reviewers. We have also attached the modified manuscript with track changes and without track change based on the editor’s and reviewers’ comments and suggestions with our resubmission. Please note that all page and line numbers we have mentioned below refer to the resubmitted manuscript with track changes.

Response to academic editor comments:

Journal requirements

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

Response: We have ensured that all style requirements are addressed.

2. For more information on PLOS ONE's expectations for statistical reporting, please see https://journals.plos.org/plosone/s/submission-guidelines.#loc-statistical-reporting. Please update your Methods and Results sections accordingly

Response: We thank you. We have done so with our resubmission.

3. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. If the original language is written in non-Latin characters, for example Amharic, Chinese, or Korean, please use a file format that ensures these characters are visible.

We have made all data, including data set and data collection tool fully available as supporting information.

Response: We have included the data collection tool used in this study that contains both English and Tigrigna version as supporting information.

4. We noticed you have some minor occurrence of overlapping text with the following previous publication(s), which needs to be addressed:

- https://tropmedhealth.biomedcentral.com/articles/10.1186/s41182-018-0091-z

In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the methods section. Further consideration is dependent on these concerns being addressed.

Response: We have paraphrased some of the overlapping texts. Actually, the overlaps are occurred just by chance. Moreover, we have cited all utilized resources.

.

Response to Reviewer comments

1. Overall, the text is well organized and structured according to IMRED. The writing style is pleasant. However, the presentation of tables does not meet current standards for presentation of a table. It will remove the left and right borders and remove the intermediate lines only the bottom line and the variable banner (the 2 top lines

Response: We appreciate the reviewer comments. We have done so with our resumption. Please see the highlighted tables (Table 1, Table 2, Table 3, and Table 4)

2. There are also shortcomings in the presentation of the references, in particular reference 17 to be corrected.

Response: We thank the reviewer’s comments and suggestions. We have corrected them with our resubmission. Please see the highlighted references with yellow colour.

3. Statistical analyses are carried out to high technical standards and are described in sufficient detail. However, we should have presented the results of the univariate analysis with the overall p value for a variable instead of the p value per variable category; especially for variables with more than 2 modalities.

Response: Thank you for your suggestions. Actually, both approaches (overall p value for a variable and p value per variable category) are possible. We have modified it according to your suggestions in our resubmission. Please see the highlights on table 4.

4. In the presentation of table 4, for the reference modality, the p value must not appear (in yellow in the table). The presentation of Table 4 needs to be improved

Response: We appreciate the reviewer comments. We have done so with our resubmission. Please see the highlights on table 4.

5. Make a clear distinction between the variables that were used for the univariate analysis and those that were retained for the multivariate analysis.

Response: We have done so with our re-submission. Please see the highlights on page 10 lines 209-221.

Attachment

Submitted filename: response to reviewers for plose one.docx

Decision Letter 1

Denis Bourgeois

3 May 2021

Self-medication practice and contributing factors among pregnant women

PONE-D-20-32462R1

Dear Dr. Niriayo,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Denis Bourgeois

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Denis Bourgeois

5 May 2021

PONE-D-20-32462R1

Self-medication practice and contributing factors among pregnant women

Dear Dr. Niriayo:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Denis Bourgeois

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Data collection instrument.

    (DOC)

    S2 Table. Dataset.

    (SAV)

    Attachment

    Submitted filename: PONE-D-20-32462_reviewer_GARE.pdf

    Attachment

    Submitted filename: response to reviewers for plose one.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES